This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

ARIAD Pharmaceuticals Inc (ARIA)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 352.69M 237.18M 119.38M 306.26M
Receivables 8.40M 1.30M 101.00K 34.00K
Inventories 979.00K 419.00K 0.00 0.00
Other Current Assets 23.58M 6.04M 3.84M 1.28M
Total Current Assets 385.64M 244.95M 168.35M 307.57M
Property, Plant & Equipment, Gross 241.85M 149.09M 43.90M 39.98M
Accumulated Depreciation & Depletion 38.83M 40.31M 36.22M 33.37M
Property, Plant & Equipment, Net 203.03M 108.78M 7.68M 6.61M
Intangibles 939.00K 968.00K 3.12M 5.74M
Other Non-Current Assets 14.26M 16.20M 1.04M 791.00K
Total Non-Current Assets 218.23M 125.95M 11.84M 13.14M
Liabilities & Shareholder Equity
Total Assets 603.87M 370.89M 180.19M 320.71M
Accounts Payable 10.82M 15.54M 8.27M 5.73M
Short Term Debt 6.71M 4.20M 2.12M 1.45M
Other Current Liabilities 17.83M 10.96M 698.00K 1.17M
Total Current Liabilities 90.00M 72.18M 48.87M 25.37M
Long Term Debt 156.91M 4.90M 9.10M 11.22M
Deferred Income Taxes 0.00 0.00 0.00 2.72M
Other Non-Current Liabilities 86.84M 8.89M 9.38M 61.26M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 433.07M 113.20M 18.48M 75.20M
Total Liabilities 523.07M 185.38M 67.34M 100.57M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 80.80M 185.52M 112.85M 220.14M
Common Par 187.00K 186.00K 167.00K 158.00K
Additional Paid In Capital 1.30B 1.24B 890.50M 776.95M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -1.21B -1.05B -777.84M -556.96M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -4.18M -1.54M 20.00K 0.00
Total Capitalization 237.71M 190.42M 121.95M 231.36M
Total Equity 80.80M 185.52M 112.85M 220.14M
Total Liabilities & Stock Equity 603.87M 370.89M 180.19M 320.71M
Total Common Shares Outstanding 187.29M 185.90M 167.08M 157.61M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 186.84M 183.58M 164.96M 132.38M
Diluted Weighted Shares Outstanding 186.84M 183.58M 164.96M 132.38M
Number of Employees 379 307 300 150
Number of Part-Time Employees 0 0 0 0

ARIA ARIAD Pharmaceuticals Inc

Chart of ARIA

Analysts Ratings for ARIA

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 3 4 4 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

ARIA Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Chris Versace, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Daily Swing Trade

Master swing trader Alan Farley uses his sophisticated software screens to review thousands of stocks each day for you, to find just the handful that meet his demanding criteria.

Product Features:
  • Daily commentary and coaching on swing trading
  • Technical charts and analysis
Top Rated Stocks Top Rated Funds Top Rated ETFs